Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post by Ashish M. Kamat, President of IBCG, Associated Editor at European Urology Oncology, on X, adding:
“Huge congrats Ashish M. Kamat, IBCG on this major milestone! Your tremendous vision and leadership has shaped the way we think about intermediate risk bladder cancer and glad to see it embraced by the National Comprehensive Cancer Network (NCCN).”
Quoting Ashish M. Kamat‘s post:
“Pleased to share that the 2026 National Comprehensive Cancer Network (NCCN) Bladder Cancer Guidelines now incorporate the IBCG risk stratification framework for intermediate-risk NMIBC.
A milestone reflecting more than a decade of collaborative work by colleagues worldwide.”
Other articles about Bladder Cancer on OncoDaily.